In order to access the Charts, please log on to your TD Ameritrade account or open an account!
IGC Pharma IncChange company Symbol lookupSelect an option...IGC IGC Pharma IncXPL Solitario Zinc CorpDD Dupont De Nemours IncRLJ RLJ Lodging TrustTTEXF Bullion Gold Resources CorpFRLN Freeline Therapeutics Holdings PLCPCQ PIMCO California Municipal Income FundWULF Terawulf IncUSB-A US BancorpDBTX Decibel Therapeutics IncGo
Change company Symbol lookup
Select an option...
IGC IGC Pharma Inc
XPL Solitario Zinc Corp
DD Dupont De Nemours Inc
RLJ RLJ Lodging Trust
TTEXF Bullion Gold Resources Corp
FRLN Freeline Therapeutics Holdings PLC
PCQ PIMCO California Municipal Income Fund
WULF Terawulf Inc
USB-A US Bancorp
DBTX Decibel Therapeutics Inc
Industrials : Trading Companies & Distributors | Small Cap Value
Company profileIGC Pharma, Inc., formerly India Globalization Capital, Inc., develops advanced cannabinoid-based formulations for treating diseases and conditions, including Alzheimer’s disease, period cramps (dysmenorrhea), premenstrual syndrome (PMS) and chronic pain. The Company has two investigational drug assets targeting Alzheimer’s disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer’s cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer’s disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol (THC) based formulation that is presently in a 146-person Phase II safety and efficacy clinical trial for agitation in dementia due to Alzheimer’s. The Company also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome, menstrual cramps, and sleep disorders.
|
|
|
|
| |
Please Log On
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
The risk of loss in trading futures can be substantial. Clients must consider all relevant risk factors, including their own personal financial situation, before trading. Margin and level 2 options approval or higher is required. Not all account owners will qualify.
Dividends are converted to USD using the current rate of exchange at the end of the business day on the day the dividend went EX. Earnings are converted to USD using the current rate of exchange at the end of the business day on the day earnings were announced.
Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.